Adsorption and release of BMP-2 on nanocrystalline apatite-coated and uncoated hydroxyapatite/β-tricalcium phosphate porous ceramics

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 91, Issue 2, 2009, Pages 706-715

  Autefage, Hélène ^a,e   Briand Mésange, Fabienne ^b   Cazalbou, Sophie ^a   Drouet, Christophe ^a   Fourmy, Daniel ^c   Gonçalvès, Stéphane ^d   Salles, Jean Pierre ^b   Combes, Christèle ^a   Swider, Pascal ^e   Rey, Christian ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU PURPAN   (France)

^c INSERM   (France)

^d ZI de Montredon ^*  (France)

^e UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Bioceramics; Biphasic calcium phosphate (BCP); Bone morphogenetic protein 2 (BMP 2); Nanocrystalline apatite; Protein adsorption and release

Indexed keywords

BIPHASIC CALCIUM PHOSPHATES; BONE MORPHOGENETIC PROTEIN-2; NANOCRYSTALLINE APATITES; PROTEIN ADSORPTION; PROTEIN ADSORPTION AND RELEASE;

ADSORPTION; ADSORPTION ISOTHERMS; ANIMAL CELL CULTURE; APATITE; ATMOSPHERIC TEMPERATURE; BIOACTIVITY; BIOCERAMICS; BIOMIMETICS; BONE; CALCIUM; CALCIUM ALLOYS; CELL CULTURE; COATINGS; PEPTIDES; PHOSPHATE MINERALS; SINTERING; SURFACE PROPERTIES;

CALCIUM PHOSPHATE;

APATITE; BIOCERAMICS; BIOMIMETIC MATERIAL; CALCIUM PHOSPHATE CERAMIC; HYDROXYAPATITE; NANOCRYSTAL; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ADSORPTION; ARTICLE; COATED PARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ISOTHERM; PARTICLE SIZE; POROSITY; PROTEIN SECRETION; SURFACE PROPERTY;

ADSORPTION; ALGORITHMS; APATITES; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATES; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; DURAPATITE; HUMANS; KINETICS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; POROSITY; POWDERS; RECOMBINANT PROTEINS; X-RAY DIFFRACTION;

EID: 71649086672     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31447     Document Type: Article

References (39)

1. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-345. (Pubitemid 40910322)
2. Boix T, Gomez-Morales J, Torrent-Burgués J, Monfort A, Puigdomènech P, Rodriguez-Clemente R. Adsorption of recombinant human bone morphogenetic protein rhBMP-2m onto hydroxyapatite. J Inorg Biochem 2005;99:1043-1050. (Pubitemid 40503068)
3. Dong X, Wang Q, Wu T, Pan H. Understanding adsorptiondesorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007;93:750-759.
4. Alam MI, Asahina I, Ohmamiuda K, Takahashi K, Yokota S, Enomoto S. Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. Biomaterials 2001;22:1643-1651. (Pubitemid 32551915)
5. Vehof JWM, Takita H, Kuboki Y, Spauwen PHM, Jansen JA. Histological characterization of the early stages of bone morphogenetic protein-induced osteogenesis. J Biomed Mater Res 2002;61:440-449. (Pubitemid 34666057)
6. Yuan H, deBruijn JD, Zhang X, vanBlitterswijk CA, de Groot K. Use of an osteoinductive biomaterial as a bone morphogenetic protein carrier. J Mater Sci Mater Med 2001;12:761-766.
7. Murata M, Akazawa T, Tazaki J, Ito K, Sasaki T, Yamamoto M, Tabata Y, Arisue M. Blood permeability of a novel ceramic scaffold for bone morphogenetic protein-2. J Biomed Mater Res Part B: Appl Biomater 2007;81:469-475. (Pubitemid 46685116)
8. Liu Y, Enggist L, Kuffer AF, Buser D, Hunziker EB. The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. Biomaterials 2007;28:2677-2686. (Pubitemid 46367217)
9. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004; 22:58-65. (Pubitemid 38035446)
10. Barroug A, Lernoux E, Lemaitre J, Rouxhet PG. Adsorption of catalase on hydroxyapatite. J Colloid Interface Sci 1998; 208:147-152.
11. Barroug A, Fastrez J, Lemaitre J, Rouxhet PG. Adsorption of succinylated lysozyme on hydroxyapatite. J Colloid Interface Sci 1997;189:37-42.
12. Hughes Wassell DT, Hall RC, Embery G. Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials 1995; 16:697-702.
13. Daculsi G, Legeros RZ. Tricalcium phosphate/Hydroxyapatite biphasic ceramics. In: Kokubo T, editor. Bioceramics and Their Clinical Applications. Cambridge, UK: Woodhead Publishing; 2008. pp 395-423.
14. Le Nihouannen D, Daculsi G, Saffarzadeh A, Gauthier O, Delplace S, Pilet P, Layrolle P. Ectopic bone formation by microporous calcium phosphate ceramic particles in sheep muscles. Bone 2005;36:1086-1093. (Pubitemid 40803450)
15. Habibovic P, Sees TM, van der Doel MA, van Blitterswijk CA, de Groot K. Osteoinduction by biomaterials-physicochemical and structural influences. J Biomed Mater Res A 2006;77:747-762.
16. Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blitterswijk CA, de Groot K. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 2005;26:3565-3575. (Pubitemid 40038151)
17. Rouahi M, Gallet O, Champion E, Dentzer J, Hardouin P, Anselme K. Influence of hydroxyapatite microstructure on human bone cell response. J Biomed Mater Res A 2006;78: 222-235. (Pubitemid 44061059)
18. Rey C, Combes C, Drouet C, Sfihi H, Barroug A. Physicochemical properties of nanocrystalline apatites: Implications for biominerals and biomaterials. Mater Sci Eng C 2007;27: 198-205. (Pubitemid 46205289)
19. Hayakawa S, Tsuru K, Osaka A. The microstructure of bioceramics and its analysis. In: Kokubo T, editor. Bioceramics and Their Clinical Applications. Cambridge, UK: Woodhead Publishing; 2008. pp 53-77.
20. Ouizat S, Barroug A, Legrouri A, Rey C. Adsorption of bovine serum albumin on poorly crystalline apatite: Influence of maturation. Mater Res Bull 1999;34:2279-2289. (Pubitemid 30589766)
21. Benaziz L, Barroug A, Legrouri A, Rey C, Lebugle A. Adsorption of o-phospho-l-serine and l-serine onto poorly crystalline apatite. J Colloid Interface Sci 2001;238:48-53. (Pubitemid 32896789)
22. Baig AA, Fox JL, Wang Z, Higuchi WI, Miller SC, Barry AM, Otsuka M. Metastable solubility equilibrium behavior of bone mineral. Calcif Tissue Int 1999;64:329-339. (Pubitemid 29165360)
23. Charlot G. Chimie Analytique Quantitative, Vol.2. Paris: Masson; 1974. pp 366-478.
24. Bohic S, Rey C, Legrand A, Sfihi H, Rohanizadeh R, Martel C, Barbier A, Daculsi G. Characterization of the trabecular rat bone mineral: Effect of ovariectomy and bisphosphonate treatment. Bone 2000;26:341-348. (Pubitemid 30136123)
25. Frolik CA, Wakefield LM, Smith DM, Sporn MB. Characterization of a membrane receptor for transforming growth factor- beta in normal rat kidney fibroblasts. J Biol Chem 1984; 259:10995-11000. (Pubitemid 14030183)
26. Ruppert R, Hoffmann E, Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 1996;237:295-302. (Pubitemid 26110301)
27. Rey C, Collins B, Goehl T, Dickson IR, Glimcher MJ. The carbonate environment in bone mineral: A resolution-enhanced Fourier transform infrared spectroscopy study. Calcif Tissue Int 1989;45:157-164. (Pubitemid 19229785)
28. Matsumoto T, Okazaki M, Inoue M, Yamaguchi S, Kusunose T, Toyonaga T, Hamada Y, Takahashi J. Hydroxyapatite particles as a controlled release carrier of protein. Biomaterials 2004;25:3807-3812. (Pubitemid 38327069)
29. Klenke FM, Liu Y, Yuan H, Hunziker EB, Siebenrock KA, Hofstetter W. Impact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo. J Biomed Mater Res A 2008;85:777-786. (Pubitemid 351632891)
30. Scheufler C, Sebald W, Hülsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2,7 Å resolution. J Mol Biol 1999;287:103-115. (Pubitemid 29134800)
31. Midy V, Rey C, Bres E, Dard M. Basic fibroblast growth factor adsorption and release properties of calcium phosphate. J Biomed Mater Res 1998;41:405-411. (Pubitemid 28300105)
32. Midy V, Hollande E, Rey C, Dard M, Plouët J. Adsorption of vascular endothelial growth factor to two different apatitic materials and its release. J Mater Sci Mater Med 2001; 12:293-298. (Pubitemid 32467580)
33. Schmoekel H, Schense JC, Weber FE, Grätz KW, Gnägi D, Müller R, Hubbell JA. Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. J Orthop Res 2004;22:376-381. (Pubitemid 38155295)
34. Uludag H, Gao T, Porter TJ, Friess W, Wozney JM. Delivery Systems for BMPs: Factors contributing to protein retention at an application site. J Bone Joint Surg Am 2001;83: 128-135.
35. Rey C, Combes C, Drouet C, Somrani S. Tricalcium phosphate- based ceramics. In: Kokubo T, editor. Bioceramics and Their Clinical Applications. Cambridge, UK: Woodhead Publishing; 2008. pp 326-366.
36. Zisch AH, Schenk U, Schense JC, Sakiyama-Elbert SE, Hubbell JA. Covalently conjugated VEGF-fibrin matrices for endothelialization. J Control Release 2001;72:101-113. (Pubitemid 32522348)
37. Liu Y, de Groot K, Hunziker EB. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. Bone 2005;36:745-757. (Pubitemid 40626762)
38. Tsujigiwa H, Nagatsuka H, Gunduz M, Rodriguez A, Rivera RS, LeGeros RZ, Inoue M, Nagai N. Effects of immobilized recombinant human bone morphogenetic protein-2/succinylated type I atelocollagen on cellular activity of ST2 cells. J Biomed Mater Res A 2005;75:210-215. (Pubitemid 41298203)
39. Coradin T, Livage J. Mesoporous alginate/silica biocomposites for enzyme immobilisation. C R Chim 2003;6:147-152. (Pubitemid 36596560)